GMV The Future, page-1209

~
23/8/2019, asx , verbatim,
US Listing Update
~

23 August 2019

G MEDICAL US LISTING UPDATE
.

Withdrawal of NASDAQ capital raising prospectus to allow for formal filing of OTC listing

Dual listing on OTCQB will be non-dilutive to existing G Medical shareholders

OTC affords the same access to institutional and individual investors

Increasing US operational and investor footprint remain a key focus

HKSE Listing of ‘Yimei’ continues
.

Mobile and e-Health company G Medical Innovations Holdings Limited (ASX: GMV) (“G Medical” or the “Company”) wishes to update its shareholders on it US Public Offering strategies.
.

The Company has made a decision to withdraw the Company's NASDAQ registration statement on form F1 filing (“F1 Prospectus”) (refer to the ASX announcement dated 20 May 2019) and will instead pursue an OTC (over the counter) listing on the OTCQB (“OTC”), a US based financial market. With the decision of the F1 Prospectus withdrawal now effectuated, the Company anticipates the filing in respect to the OTC listing with the US Securities and Exchange Commission (SEC) to occur in the coming weeks …..”

~

Dyor.
At least read this asx ann in full.

~
ps
As mentioned, yacov is likely to revisit Nasdaq/CR after he gets Nmpa/Boletong/Silverlake & HKSE/GYimei, later this year